What is Onego Bio?
Onego Bio operates at the intersection of synthetic biology and food technology, leveraging a commercially proven Trichoderma technology to produce animal-free egg proteins. By utilizing precision fermentation, the company offers a sustainable alternative to traditional poultry-derived ingredients, effectively decoupling protein production from industrial farming. This market position is critical as global demand for sustainable, high-quality protein sources continues to rise, positioning Onego Bio as a key innovator in the transition toward a more resilient and environmentally conscious food supply chain.
How much funding has Onego Bio raised?
Onego Bio has raised a total of $71M across 4 funding rounds:
Angel/Seed
$11.3M
Grant
$4.5M
Series A
$40M
Other Financing Round
$15.2M
Angel/Seed (2022): $11.3M with participation from Agronomics and Maki.vc
Grant (2022): $4.5M led by Tem
Series A (2024): $40M supported by Business Finland, Maki.vc, and Agronomics
Other Financing Round (2024): $15.2M featuring The European Innovation Council
Key Investors in Onego Bio
Maki.vc
Maki.vc is an early-stage European venture capital firm specializing in supporting deep tech and brand-driven startups at the pre-seed and seed stages, with a focus on long-term sustainability.
Agronomics
Agronomics Limited is a leading London-listed company focusing on investment opportunities within the field of cellular agriculture, specifically utilizing biotechnology to produce proteins.
Business Finland
Business Finland is a public organization that provides innovation funding and internationalization services to promote sustainable economic growth and competitiveness for Finnish companies.
What's next for Onego Bio?
With the recent influx of capital, Onego Bio is well-positioned to transition from pilot-scale operations to full-scale commercialization. The company's strategic roadmap focuses on scaling its fermentation infrastructure and navigating regulatory pathways to bring its bio-identical egg proteins to international markets. By maintaining strong partnerships with both public innovation bodies and specialized venture capital firms, Onego Bio is poised to disrupt the traditional egg industry, setting a new standard for efficiency and sustainability in the global food technology landscape.
See full Onego Bio company page
